| Trial ID: | L0694 |
| Source ID: | NCT01380717
|
| Associated Drug: |
Beta-Blocker, Ace-Inhibitor
|
| Title: |
Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)
|
| Acronym: |
RenVas
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Insufficiency|Hypertension|Vasodilation
|
| Interventions: |
DRUG: Beta-blocker, ACE-inhibitor|DRUG: Calcium Channel Blockers, ACE-Inhibitor
|
| Outcome Measures: |
Primary: Change in glomerular filtration rate between the two treatment arms., Measured at baseline and after 18 months of treatment | Secondary: Changes in glomerular filtration rate stratified after changes in pulse wave velocity, renal vascular resistance and forearm minimal resistance at baseline and after 18 months of treatment., 18 months
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
83
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-02
|
| Completion Date: |
2014-02
|
| Results First Posted: |
|
| Last Update Posted: |
2014-02-27
|
| Locations: |
Department of Renal Medicine, Aarhus University Hospital, Skejby, Aarhus N, 8200, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01380717
|
